GR66630B - - Google Patents

Info

Publication number
GR66630B
GR66630B GR61403A GR800161403A GR66630B GR 66630 B GR66630 B GR 66630B GR 61403 A GR61403 A GR 61403A GR 800161403 A GR800161403 A GR 800161403A GR 66630 B GR66630 B GR 66630B
Authority
GR
Greece
Application number
GR61403A
Other languages
Greek (el)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of GR66630B publication Critical patent/GR66630B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR61403A 1979-03-14 1980-03-11 GR66630B (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH241579 1979-03-14
CH17180 1980-01-10

Publications (1)

Publication Number Publication Date
GR66630B true GR66630B (enExample) 1981-04-03

Family

ID=25683737

Family Applications (1)

Application Number Title Priority Date Filing Date
GR61403A GR66630B (enExample) 1979-03-14 1980-03-11

Country Status (10)

Country Link
EP (1) EP0016371A1 (enExample)
AU (1) AU5628380A (enExample)
DK (1) DK108780A (enExample)
ES (1) ES8103737A1 (enExample)
FI (1) FI800559A7 (enExample)
GR (1) GR66630B (enExample)
IL (1) IL59563A0 (enExample)
MC (1) MC1317A1 (enExample)
NO (1) NO800720L (enExample)
PT (1) PT70949B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
ATE538794T1 (de) 1999-01-13 2012-01-15 Bayer Healthcare Llc Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
RU2319693C9 (ru) 1999-01-13 2008-08-20 Байер Копэрейшн Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
US7838541B2 (en) 2002-02-11 2010-11-23 Bayer Healthcare, Llc Aryl ureas with angiogenesis inhibiting activity
US20030216396A1 (en) 2002-02-11 2003-11-20 Bayer Corporation Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors
PT1580188E (pt) 2002-02-11 2012-01-25 Bayer Healthcare Llc Aril-ureias como inibidores de cinases
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
WO2004113274A2 (en) 2003-05-20 2004-12-29 Bayer Pharmaceuticals Corporation Diaryl ureas with kinase inhibiting activity
RS52625B (sr) 2003-07-23 2013-06-28 Bayer Healthcare Llc Fluoro supstituisana omega-karboksiaril difenil urea za lečenje i prevenciju bolesti i stanja bolesti
ATE517885T1 (de) 2004-04-30 2011-08-15 Bayer Healthcare Llc Substituierte pyrazolyl-harnstoff-derivate zur behandlung von krebs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448869A1 (de) * 1973-10-19 1975-09-04 Mcneilab Inc 4-oxo-2-imidazolidinylidenharnstoffe, verfahren zu ihrer herstellung und arzneimittel
US3983135A (en) * 1974-09-23 1976-09-28 Mcneil Laboratories, Incorporated 4-Oxo-2-imidazolidinylidene ureas
US4025517A (en) * 1975-06-23 1977-05-24 Mcneil Laboratories, Incorporated 4-Oxo-2-hexahydropyrimidinylidene ureas

Also Published As

Publication number Publication date
PT70949A (en) 1980-04-01
FI800559A7 (fi) 1981-01-01
ES489493A0 (es) 1981-03-16
IL59563A0 (en) 1980-06-30
AU5628380A (en) 1980-09-18
DK108780A (da) 1980-09-15
ES8103737A1 (es) 1981-03-16
PT70949B (en) 1981-06-24
MC1317A1 (fr) 1981-03-10
EP0016371A1 (de) 1980-10-01
NO800720L (no) 1980-09-15

Similar Documents

Publication Publication Date Title
FR2446336B1 (enExample)
FR2447856B1 (enExample)
FR2445757B1 (enExample)
FR2446020B1 (enExample)
JPS55155688U (enExample)
FR2448676B1 (enExample)
FR2466698B1 (enExample)
FR2447503B1 (enExample)
GR66630B (enExample)
FR2461576B1 (enExample)
FR2447863B1 (enExample)
FR2446253B1 (enExample)
IN150324B (enExample)
FR2446848B1 (enExample)
FR2471661B3 (enExample)
FR2446727B1 (enExample)
FR2467667B1 (enExample)
FR2448386B1 (enExample)
FR2459616B3 (enExample)
FR2447388B1 (enExample)
FR2446469B1 (enExample)
FR2447434B1 (enExample)
FR2447132B1 (enExample)
FR2450480B1 (enExample)
FR2464803B3 (enExample)